Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine

NCT04833101 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

NETWORK

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: recombinant Ad5 vectored COVID-19 vaccine
BIOLOGICAL: RBD-based protein subunit vaccine (ZF2001) against COVID-19
BIOLOGICAL: trivalent split influenza vaccine

Sponsor

Jiangsu Province Centers for Disease Control and Prevention